Global Pharmaceuticals & Biotech Breakout Stocks

Moderna

Market Cap: US$25.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$23.3b

Engages in the development and commercialization of immunotherapies in Germany.

Amylyx Pharmaceuticals

Market Cap: US$3.9b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Eton Pharmaceuticals

Market Cap: US$1.8b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Maravai LifeSciences Holdings

Market Cap: US$1.5b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Omeros

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Kura Oncology

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Climb Bio

Market Cap: US$998.8m

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

Candel Therapeutics

Market Cap: US$922.0m

A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.

Hubei Biocause Heilen Pharmaceutical

Market Cap: CN¥6.1b

Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Boji Medical TechnologyLtd

Market Cap: CN¥5.9b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

4D Molecular Therapeutics

Market Cap: US$813.2m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Achieve Life Sciences

Market Cap: US$773.8m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Assembly Biosciences

Market Cap: US$654.2m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.9b

Operates as a pharmaceutical manufacturing holding investment company in China.

OmniAb

Market Cap: US$569.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥3.5b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

Morepen Laboratories

Market Cap: ₹48.5b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd

Market Cap: CN¥2.5b

Engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China.

AVITA Medical

Market Cap: US$304.6m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Cardiol Therapeutics

Market Cap: CA$304.9m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Acumen Pharmaceuticals

Market Cap: US$198.1m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Nykode Therapeutics

Market Cap: NOK 1.6b

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

Apollomics

Market Cap: US$52.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Valiant Laboratories

Market Cap: ₹5.0b

Operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.

Bilcare

Market Cap: ₹2.3b

Provides pharmaceutical packaging research solutions in India and internationally.

NextCell Pharma

Market Cap: SEK 163.0m

A biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.

Brainstorm Cell Therapeutics

Market Cap: US$15.6m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Pharmala Biotech Holdings

Market Cap: CA$20.2m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Aton

Market Cap: €12.4m

Operates as a bioscience company in France.

Dannex Ayrton Starwin

Market Cap: GH₵75.4m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.

Nuformix

Market Cap: UK£4.8m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

International Stem Cell

Market Cap: US$3.9m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

1933 Industries

Market Cap: CA$5.2m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Enzolytics

Market Cap: US$3.4m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Zenith Capital

Market Cap: US$3.2m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.